Ertugliflozin API

Xi'an Sonwu Biotech Co., Ltd. is one of the most professional manufacturers and suppliers of ertugliflozin api in China. We warmly welcome yuo to wholesale bulk ertugliflozin api for sale here from our factory. Quality products and reasonable price are available.

What Is Ertugliflozin

Ertugliflozin API is an oral hypoglycemic medication that is a member of the sodium-glucose cotransporter 2 inhibitor (SGLT2) class. Patients with type 2 diabetes mellitus (T2DM) mostly utilize it for glycemic control, often as an adjunct therapy when diet and exercise are ineffective. This product was approved by the FDA in 2017 and is included in various combination therapies, such as Segluromet® with metformin and Steglujan® with sitagliptin. Unlike traditional hypoglycemic agents (such as sulfonylureas and insulin), ertugliflozin's hypoglycemic effect is independent of insulin secretion, thus it can also be effective in diabetic patients with impaired pancreatic function. This unique mechanism makes it an important component of modern hypoglycemic therapy.

This product is used to treat high blood sugar levels brought on by type 2 diabetes when combined with a healthy diet and regular exercise. It functions in the kidneys to stop glucose (blood sugar) from being absorbed. The blood sugar level is lowered as a result. Patients with type 1 or insulin-dependent diabetes are not helped by ertugliflozin. Patients with type 1 diabetes require insulin shots.

Certificate Of Analysis

Where To Buy Ertugliflozin

Xi'an Sonwu Biotech Co. Ltd. has rich experience in the global trade and health industry. Insisting on faith-based and quality first is our company's principle. We strictly control product quality, which means selection starts from raw materials. Besides, we handle every detail and reduce the cost to the maximum extent, then our customers can get cost-effective products. Based on these, customers have given much good feedback to our products. So you can look for Xi'an Sonwu Biotech Co. Ltd. when you want to buy Ertugliflozin powder.

Xi'an Sonwu completely makes sure of the product's quality, so samples can be supplied. Here is the quantity.

Customers' Good Comment

What Is The Mechanism Of Action Of Ertugliflozin

Epagliflozin lowers blood glucose by inhibiting the SGLT2 transporter in the kidneys. Normally, the kidneys reabsorb glucose filtered from the blood daily, with approximately 90% of this reabsorption handled by the SGLT2 protein and the remaining 10% by SGLT1. When elegliflozin binds to SGLT2 and inhibits its activity, glucose cannot be reabsorbed and is instead excreted in the urine, thus lowering blood glucose levels. This mechanism results in three significant metabolic effects:

1. Direct reduction of blood glucose levels: Blood glucose is reduced through urinary glucose excretion without the need for insulin;

2. Weight reduction: Urine removes between 200 and 300 kcal of energy each day, which causes a slight reduction in weight;

3. Lowering blood pressure: Due to increased urinary sodium excretion (mild diuresis), systolic and diastolic blood pressure are slightly lowered.

It is noteworthy that elegliflozin has extremely high selectivity for SGLT2 (approximately 2000 times that for SGLT1), therefore it has almost no impact on intestinal glucose absorption and is well-tolerated by the gastrointestinal tract.

What Is The Drug Ertugliflozin Used For

Ertugliflozin is primarily used to treat type 2 diabetes (mellitus), with its core function being to help lower blood glucose levels. It belongs to a new type of oral hypoglycemic agent called an SGLT2 inhibitor (sodium-glucose cotransporter 2 inhibitor), which lowers blood glucose by acting on the kidneys rather than stimulating insulin secretion. This makes it effective for patients with impaired pancreatic function or insulin resistance, making it an important option in modern diabetes management.

The main mechanism of action is the inhibition of the SGLT2 transporter in the proximal renal tubules. By blocking SGLT2, ertugliflozin prevents glucose from being reabsorbed, thus causing it to be excreted in the urine. This "glucose-excreting" mechanism directly lowers blood glucose levels and is independent of insulin, therefore reducing the risk of hypoglycemia.

In addition to its blood glucose-lowering effect, Ertugliflozin API also has some weight- and blood pressure-lowering effects. Because urinary glucose excretion removes some calories, patients often experience mild weight loss; simultaneously, the drug also promotes sodium excretion, thereby mildly lowering blood pressure. These additional benefits are particularly beneficial for obese patients or those with hypertension.

Egliflozin is commonly used in adults with type 2 diabetes whose blood sugar is not adequately controlled by diet and exercise. It can be used as monotherapy or in combination with other glucose-lowering medications (such as metformin, DPP-4 inhibitors, or insulin) to enhance glycemic control. In clinical practice, combination formulations such as Segluromet (eleflozin + metformin) and Steglujan (eleflozin + sitagliptin) are also widely used.

In general, the primary use of eleflozin is to help control blood sugar in patients with type 2 diabetes by promoting glucose excretion in urine, while also providing additional health benefits such as mild weight loss and improved blood pressure. It has a relatively high safety profile, but risks of kidney function problems, urinary tract infections, and dehydration should still be considered when using it.

What Are The Precautions For Dapagliflozin

The majority of individuals tolerate ertugliflozin well, and its side effects are usually modest. However, this special mechanism also causes certain negative effects since it reduces blood sugar through the kidneys by excreting glucose.

I. Common Side Effects (occurring in most patients)

These reactions are usually mild and gradually subside as the body adapts:

Urinary tract infections (especially urinary tract infections)

Gentle fungal infections

Polyuria and frequent urination

Mild dehydration, dizziness, or low blood pressure

Mild weight loss

II. Uncommon Side Effects (occurring in a few patients)

Thirst and mild dehydration

Elevated blood ketone bodies

Mildly elevated blood lipids (LDL):

What Are The Precautions For Dapagliflozin

When using this product, the following points should be noted:

1. Renal function assessment: The drug mainly acts on the renal tubules; therefore, renal function (eGFR) should be monitored regularly before and during use. If eGFR < 45 mL/min/1.73m², the drug is not recommended because the efficacy will be significantly reduced and the risk of adverse reactions will increase. Regularly monitor kidney function and blood ketone levels, especially for those with impaired kidney function or those using insulin.

2. Risk of dehydration and hypotension: It has a mild diuretic effect, which may lead to decreased blood volume. Elderly individuals, those taking diuretics, or those with low blood pressure are prone to dizziness, hypotension, and dehydration; adequate hydration is essential.

3. Urinary tract infections: Increased glucose concentration in urine promotes bacterial and fungal growth, especially in women who may experience vulvar candidiasis or urinary tract infections. Seek medical attention immediately if itching or painful urination occurs.

4. Diabetic ketoacidosis (DKA): Although rare, SGLT2 inhibitors can induce "euglucose ketoacidosis" even when blood sugar is not high. If persistent nausea, shortness of breath, extreme weakness, or other abnormal symptoms occur, ketoacidosis should be suspected, and immediate medical attention is necessary.

Special populations:

This drug is not recommended for pregnant or breastfeeding women, as animal studies have shown it may affect fetal kidney development; it is contraindicated in patients with type 1 diabetes, as it increases the risk of ketoacidosis; elderly patients should have a lower initial dose and be closely monitored for electrolyte balance.

Factory

1. Xi'an Sonwu has a factory with sufficient stock. In addition, Xi'an Sonwu has a clean and tidy production department with advanced equipment. Under the company's leadership, researchers continue to develop new products to meet customers' needs.

2. Xi'an Sonwu has advanced testing equipment and professional testing personnel, all of which show that Xi'an Sonwu aims to provide accurate and effective data and good service.

Certificate

Package

Logistics Update

In addition to guaranteeing product quality, the other most vital thing is clients could receive the goods smoothly. So, Xi'an Sonwu supplies all kinds of couriers according to different needs.

Company's Profile

Xi'an Sonwu Biotech Co., Ltd is a professional Chinese manufacturer and products supplier. It was founded in 2012 and is located in the Hi-Tech Industrial Zone, Xi'an City, Shannxi Province, China. It pays all attention to the development, research, and production of food additives, plants, extract, APl, and other ingredients of health care products. The company supplies five kinds of raw material products: Anti-hair loss Powders, Nootropic, API, Muscle Building products, and Plant Extract. Xi'an Sonwu sincerely believes that the premise of great cooperation is the best service and good quality. So, welcome your inquiry.

And if you want to know the Ertugliflozin API price, please contact XI'an Sonwu.

Email: sales@sonwu.com

Hot Tags: ertugliflozin api, China, suppliers, manufacturers, factory, wholesale, buy, price, bulk, pure, raw, supply, for sale, NMN Nicotinamide Mononucleotide Supplement, Baclofen Powder, Cabozantinib S malate API, Chlorin E6, Sodium 2 hydroxybenzenesulfonate Powder, AB1010 Powder